By improving insulin sensitivity, blood glucose control, blood pressure and overall metabolic health, GLP-1 agonists may help address several underlying drivers of kidney stone disease
In principle, that could aid the repair of an injured tendon or ligament
Selective inhibition by triacsin C and thiazolidinediones
J Clin Med 13(18):5627 Hiramoto B, McCarty TR, Lodhia NA, Jenkins A, Elnaiem A, Muftah M, Flanagan R, Chan WW (2024) Quantified metrics of gastric emptying delay by glucagon-like peptide-1 agonists: a systematic review and meta-analysis with insights for periprocedural management
ENDED: MT2 Completed: May 24, 2024 MT1 BEGAN: MT1 10 units June 3, 2024 ENDED: MT1 20 Units August 12, 2024